BioCentury | Dec 17, 2020
Product Development

Two non-amyloid therapies for Alzheimer’s advance to late-stage trials

...idea that azeliragon might sit at the crossroads...
BioCentury | Mar 15, 2019
Product Development

Fresh AIMMs for elite responders

...from EMA. John Womelsdorf, who became AIMM’s CEO last year, said the company reached a crossroads...
BioCentury | Oct 23, 2018
Politics & Policy

FDA meeting will revisit diabetes CVOTs, decade-old controversy

...for low-risk patients unless or until their safety in higher-risk patients is assessed (see "CVOT Crossroads"...
BioCentury | Oct 22, 2018
Politics & Policy

FDA advisory committee to consider CV studies for diabetes drugs

...its CVOT mandates for diabetes drugs to reduce barriers to diabetes drug development (see "CVOT Crossroads"...
BioCentury | Sep 17, 2018
Politics & Policy

FDA to re-examine diabetes CVOT requirements

...diabetes drug has demonstrated a CV risk, and some even had cardioprotective benefits (see "CVOT Crossroads"...
BioCentury | Oct 13, 2017
Finance

Computational crossroad

After testing the waters with a handful of life sciences investments, Menlo Ventures has hired partner Greg Yap to ramp up the firm's return to the sector, this time with a bent towards computational biology....
BioCentury | Aug 31, 2017
Targets & Mechanisms

Necroptosis strikes again

...it induces necroptosis or apoptosis. Yuan said it is well-established that RIPK1 sits at the crossroads...
BioCentury | Sep 1, 2016
Translation in Brief

Bacteria with a pulse

...or immune-stimulating proteins in a mouse model of metastatic cancer, placing the bugs at the crossroads...
BioCentury | Jan 4, 2016
Product Development

Turnabout

...England Journal of Medicine (2013) Usdin, S. "Josh Hardy chronicles." BioCentury (2014) Usdin, S. "Viral crossroads."...
BioCentury | Nov 16, 2015
Regulation

Scaling compassion

...Silver Spring, Md. References Usdin, S. "Josh Hardy chronicles." BioCentury (2014) Usdin, S. "Viral crossroads."...
Items per page:
1 - 10 of 35
BioCentury | Dec 17, 2020
Product Development

Two non-amyloid therapies for Alzheimer’s advance to late-stage trials

...idea that azeliragon might sit at the crossroads...
BioCentury | Mar 15, 2019
Product Development

Fresh AIMMs for elite responders

...from EMA. John Womelsdorf, who became AIMM’s CEO last year, said the company reached a crossroads...
BioCentury | Oct 23, 2018
Politics & Policy

FDA meeting will revisit diabetes CVOTs, decade-old controversy

...for low-risk patients unless or until their safety in higher-risk patients is assessed (see "CVOT Crossroads"...
BioCentury | Oct 22, 2018
Politics & Policy

FDA advisory committee to consider CV studies for diabetes drugs

...its CVOT mandates for diabetes drugs to reduce barriers to diabetes drug development (see "CVOT Crossroads"...
BioCentury | Sep 17, 2018
Politics & Policy

FDA to re-examine diabetes CVOT requirements

...diabetes drug has demonstrated a CV risk, and some even had cardioprotective benefits (see "CVOT Crossroads"...
BioCentury | Oct 13, 2017
Finance

Computational crossroad

After testing the waters with a handful of life sciences investments, Menlo Ventures has hired partner Greg Yap to ramp up the firm's return to the sector, this time with a bent towards computational biology....
BioCentury | Aug 31, 2017
Targets & Mechanisms

Necroptosis strikes again

...it induces necroptosis or apoptosis. Yuan said it is well-established that RIPK1 sits at the crossroads...
BioCentury | Sep 1, 2016
Translation in Brief

Bacteria with a pulse

...or immune-stimulating proteins in a mouse model of metastatic cancer, placing the bugs at the crossroads...
BioCentury | Jan 4, 2016
Product Development

Turnabout

...England Journal of Medicine (2013) Usdin, S. "Josh Hardy chronicles." BioCentury (2014) Usdin, S. "Viral crossroads."...
BioCentury | Nov 16, 2015
Regulation

Scaling compassion

...Silver Spring, Md. References Usdin, S. "Josh Hardy chronicles." BioCentury (2014) Usdin, S. "Viral crossroads."...
Items per page:
1 - 10 of 35